Manufacture Advanced Medicine, Supply Chain

Video Interview: Tamas Masztis

We talk about Tamas' career and what's going on in the cell therapy space...

12/04/2021 | Interview

What are the biggest trends in cell and gene therapy? We recently interviewed a few speakers from Advanced Therapies Integrates to get their views!What are the biggest trends in cell and gene therapy? We recently interviewed a few speakers from Advanced Therapies Integrates to get their views!

Here, we speak with Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company. Tamas built one of the first cell therapy supply chains for Europe and Israel. The successful implementation of this complex, centralized end-to-end supply chain involving the transportation of patient cells has been critical to launching Kite’s cell therapies in 24 countries in the region to date.

In part 1 of this interview, we ask Tamas what inspired his interest in sourcing and supply chains, and find out more about his role at Kite.

In part 2, we delve into the wider cell and gene therapy space, including supply chain challenges and the impact of the pandemic.

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.